05 Feb 2021

Citywire's Investment Trust Insider: ICG Enterprise’s bumper quarter as cheap private equity trusts surprise

Citywire's Investment Trust Insider

Jeremy Gordon

Link to original article here

ICG Enterprise (ICGT) has become the latest listed private equity trust to report surprisingly buoyant performance in the second half of 2020, with analysts reporting the wider sector has weathered the Covid-19 storm, creating an opportunity in funds’ lagging shares.

The £649m investment company run by Intermediate Capital Group, which combines a fund-of-funds approach with co-investments and group-sourced plays in the managers’ highest conviction holdings, reported its underlying portfolio had recovered strongly from August to the end of October. 

Net asset value (NAV) shot up to £12.43 per share, up from £12.13p three months prior, with a 10.7% total return over the quarter. That put the portfolio in positive territory for 2020, returning 9.6% over the previous nine months, with private equity funds more broadly holding up better during the pandemic than they did in the financial crisis. 

ICGT’s shares were trading up 1%, or 10p, at 986p this morning and are up 2.8% over the week. The trust is currently trading on a 21% discount to NAV.

Oliver Gardey, lead manager along with Colm Walsh, said it was ‘particularly encouraging’ how strong returns in the quarter had borne out their strategy. The managers focus on top private equity funds in Europe and the US and have tried to proactively build a resilient portfolio with ‘defensive growth’ characteristics.

Gardey said they were always confident they could weather a downturn but now had nine months of data to back that up, as the portfolio’s  defensive characteristics had ‘really shined through’. He also highlighted that gains had been powered by the ‘high conviction’ segment, where the team effectively cherry-pick their favourite ideas from the funds they invest in.

This portion – which makes up just under half the portfolio – delivered local currency returns of 17.6% in the quarter.

As well as profitable realisations, that has been driven by strong performance at Telos, Leaf Home Solutions and PetSmart, all US companies in the top 10 holdings. Cybersecurity company Telos’s shares have doubled since it listed in November, while PetSmart has benefited the strong performance of listed subsidiary Chewy.

In Europe, Walsh picked out Germany’s Minimax, a leading global supplier of fire protection systems and services, as ‘a really good example of defensive growth’. Even though its customer base includes airports, it has not experienced the same downturn because the components and services it provides continue to be essential and often underpinned by regulation.  

‘I think the last big point is we’re seeing this momentum continuing into [the fourth quarter]. So, this is not just an outlier of a quarter,’ added Gardey.

Given the NAV is for the end of October, some of the ‘vaccine bounce’ seen in public markets since will also be reflected when the end of January valuation is published with the annual results. 

Gardey said that could be subtle, given a cautious approach to valuations. But he pointed out the pattern of asset sales at prices well above carrying value on the balance sheet, even during a tumultuous period.

In the first nine months of 2020, there were 22 realisations at an average uplift of 40%. The previously-reported sale of Dutch holiday park operator Roompot, which boosted NAV by 1.3%, also completed during the quarter.

Stifel: sector may surprise

In a report on London-listed private equity funds this week, Stockbroker Stifel argued the wider sector is about to deliver a positive surprise.

Its investment company analysts, led by managing director Iain Scouller, wrote:

‘With the [end of December] reporting season imminent we think the private equity sector NAVs may well surprise on the upside. When combined with the relatively large discount many of the funds are trading on, this makes the sector look attractive…

‘The rally in listed markets in Q4 has boosted comparable valuations and many funds have significant exposure to the technology and healthcare sectors which have performed strongly.’

Analysts pointed to meaningful realisations during 2020, including significant activity at NB Private Equity (NBPE) and ICG Enterprise’s accretive Roompot sale, suggesting there was plenty of latent value in portfolios.

Trusts with high healthcare and tech-related exposure could particularly benefit if valuations move upwards in line with public markets. That would boost HarbourVest Global Private Equity (HVPE) and Pantheon International (PIN), two funds of funds with more than half their portfolios across those areas. 

Although IGCT would be a smaller beneficiary of that trend, about a third of the portfolio is held across those two sectors, according to Stifel.

‘Crazy’ discount

Since autumn, ICGT has made some progress on its discount, which has fallen from around 25% to now trade in the low double-digits.

Gardey, who said he had been buying shares himself, said the pair is still ‘not satisfied’ and lambasted the discount as ‘crazy’, given the latest showing of strong performance. He believes that discounts remain too wide across the sector as a whole, given final quarter guidance suggesting performance will continue to be strong across the sector.

The managers made £30m of new investments in the quarter, taking the total to £82m for the nine months.

Since the end of October, there have also been realisations of City & County Healthcare Group and System One, while £48m was deployed in the final two months of the year.

New high conviction investments have been made into Curium, a leader in the specialised field of nuclear medicine, and AML RightSource, which provides anti-money laundering services to banks. Around £35m has also been committed to funds, including a new relationship with FSN Capital in Northern Europe.

In the past five year, shareholders have enjoyed a 96% total return with dividends reinvested, lagging the 148% average in the Association of Investment Companies’ Private Equity sector.

After the update, Stifel’s Scouller reiterated his ‘buy’ recommendation on ICGT and increased the ‘fair value’ price to 1080p, representing a 15% discount to estimated NAV.

In this week’s note, other trusts rated as a ‘buy’ by the broker included NB Private Equity, Pantheon, Standard Life Private Equity (SLPE), HarbourVest and Princess Private Equity (PEY). The latter two were both upgraded from ‘hold’ after publishing strong NAVs.

Share price (ICGT)

-14.00P (-1.30%)
8:26PM 1 Jul 2022
The share price information is delayed by at least 15 minutes

NAV per share

As of 30 April 2022
Full year results for the twelve months ended 31 January 2022
Year Net assets NAV per share Share price Dividends per share
Jan 2022 £1,158m 1,690p 1,200p 27p
Jan 2021 £952m 1,384p 966p 24p
Jan 2020 £794m 1,152p 966p 23p
Jan 2019 £731m 1,057p 822p 22p
Jan 2018 £664m 959p 818p 21p
Jan 2017 £613m 871p 698p 20p
Jan 2016 £521m 731p 545p 11p
Jan 2015 £507m 695p 575p 15.5p
Jan 2014 £494m 677p 563p 15.5p
Jan 2013 £460m 631p 487p 5p
Jan 2012 £415m 569p 357p 5p
Jan 2011 £389m 534p 308p 2.25p
Dec 2009 £338m 464p 305p 2.25p
Dec 2008 £327m 449p 187p 4.5p


The information contained herein and on the pages that follow does not constitute an offer to sell, or the solicitation of an offer to acquire or subscribe for, any securities in any jurisdiction where such an offer or solicitation is unlawful or would impose any unfulfilled registration, qualification, publication or approval requirements on ICG Enterprise Trust PLC (the "Company") or its affiliates or agents. Equity securities in the Company have not been and will not be registered under the applicable securities laws of the United States, Australia, Canada, Japan or South Africa (each an “Excluded Jurisdiction”). The equity securities in the Company referred to herein and on the pages that follow may not be offered or sold within an Excluded Jurisdiction, or to any U.S. person ("U.S. Person") as defined in Regulation S under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or to any national, resident or citizen of an Excluded Jurisdiction.

The promotion of the Company and the distribution of this website and the materials contained by it in the United Kingdom are restricted by law. Accordingly, this website and any materials contained by it should only be accessed by, and are directed only at:
(i) persons outside the United Kingdom to whom it is lawful to communicate to; or
(ii) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the “Order”); or
(iii) high net worth companies, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the Order, provided that in each case the website and any materials in are only directed at persons who are "qualified investors" as defined in article 2(1)(e) of Directive 2003/71/EC (as amended) (the "Prospectus Directive") ("Relevant Persons"). Accordingly, this website does not constitute, and does not contain the information required to be contained in, a prospectus as required under the Prospectus Directive.

This website is communicated by ICG Alternative Investment Limited (“ICG AIL”), which is authorised and regulated by the UK Financial Conduct Authority. In communicating this website ICG AIL is acting for the Company and is not responsible for advising persons viewing this website or any other person, or for providing them with the protections which would be given to those who are clients of ICG AIL under the rules of the FCA.
The information on the pages that follow may contain forward looking statements. Any statement other than a statement of historical fact is a forward looking statement. Actual results may differ materially from those expressed or implied by any forward looking statement. The Company does not undertake any obligation to update or revise any forward looking statements. You should not place undue reliance on any forward looking statement, which speaks only as of the date of its issuance.

Your access to this website is governed by the above terms. The Company may change these terms. The changes will be posted on the website. Your access to this website is governed by the version of these terms then in force.

By clicking "I understand and agree" below, you represent, warrant and agree that you (1) have read and understood these terms and the other information set out above, (2) agree to be bound by the terms, (3) do not have a registered address in, and are not resident or located in, an Excluded Jurisdiction (or, if you do, you will not seek to make any investment in the securities of the Company), (4) are not a U.S. Person or a national, resident or citizen of an Excluded Jurisdiction (or, if you are, you will not seek to make any investment in the securities of the Company), (5) are permitted under applicable laws and regulations to receive the information contained in the pages that follow, and (6) agree that you will not transmit or otherwise send any information contained in this website to any person in the United States or to any U.S. Person for the purpose of that person considering an investment in the securities of the Company, or to any publication with a general circulation in the United States.
If you cannot so certify and agree, you must click the button labelled "I decline" or otherwise exit this website.